Monitor for Form 144 filings or 10b5-1 plan disclosures; this volume of derivative exercise and sale may indicate a planned liquidity event rather than negative sentiment. No material fundamental change is implied.
Price Chart
Executive Summary
United Therapeutics CEO Martine Rothblatt and several insiders engaged in a series of derivative exercises and open-market sales over a 3-day period, including $1.39M in open-market share sales by Rothblatt and $2.8M in derivative exercises at non-zero cost. The activity is part of a structured transaction plan, not opportunistic selling.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 9,779 shares in open market for $1.52M across two transactions on March 3 and March 5, 2026.
- Rothblatt exercised 38,000 derivative securities in total, with $2.77M of those exercises at $146.03 per share (cash-out or cashless exercise).
- Other insiders (EVP, directors) exercised derivatives totaling $1.92M in value at non-zero cost, with additional non-cash exercises (tax withholding or awards).
- Total open-market sales in cluster: $1.55M (Rothblatt $1.52M, Malcolm Jan $25,460).
- Total derivative exercises with cash cost: $4.69M (Rothblatt $2.77M, Mahon $1.21M, Kurzweil $0.50M, Thompson $0.20M, Causey $2.4K).
- All transactions occurred between March 3–5, 2026, suggesting a coordinated, pre-arranged plan.
Financial Impact
$1.55M in open-market sales and $4.69M in cash-backed derivative exercises over 3 days
Risk Factors
- Perception of insider selling pressure despite structured nature
- Potential for short-term price sensitivity if retail interprets sales as bearish
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (16 trades, 7d window) | cluster-UTHR-1773088594190 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $573.51 (+14.62%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $573.51 (+15.37%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $573.51 (+13.82%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $573.51 (+13.16%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $573.51 (+17.62%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $573.51 (+17.48%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $573.51 (+11.26%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $573.51 (+8.64%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $573.51 (+11.00%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $573.51 (+11.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access